Treating the most vulnerable and costly in diabetes

David V. Wagner, Maggie Stoeckel, Megan E. Tudor, Michael Harris

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Diabetic ketoacidosis (DKA) is associated with negative health outcomes and high costs for patients, families, and communities. Interventions developed to effectively reduce DKA and related costs should target the multiple risk factors associated with DKA and adherence difficulties. Certain demographic, psychological, and family factors are associated with increased risk for adherence problems and DKA. Individuals with a combination of risk factors (e.g., mental health problems, low socioeconomic status, high family conflict) may be particularly vulnerable to DKA. Although several different interventions have demonstrated promise in improving adherence and/or decreasing the risk of DKA, the generalizability of treatment results to those individuals most vulnerable to DKA is limited. Approaches which include multiple evidence-based components of care, are flexible in treatment delivery (e.g., home- and community-based, utilize technology), and target the multiple risk factors across relevant systems (e.g., individual, family, school, medical) are warranted to effectively reduce DKA in vulnerable populations.

Original languageEnglish (US)
Pages (from-to)606
Number of pages1
JournalCurrent Diabetes Reports
Volume15
Issue number6
DOIs
StatePublished - Jun 1 2015

Fingerprint

Diabetic Ketoacidosis
Costs and Cost Analysis
Family Conflict
Vulnerable Populations
Medical Schools
Social Class
Mental Health
Demography
Psychology
Technology
Health
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Treating the most vulnerable and costly in diabetes. / Wagner, David V.; Stoeckel, Maggie; E. Tudor, Megan; Harris, Michael.

In: Current Diabetes Reports, Vol. 15, No. 6, 01.06.2015, p. 606.

Research output: Contribution to journalArticle

Wagner, David V. ; Stoeckel, Maggie ; E. Tudor, Megan ; Harris, Michael. / Treating the most vulnerable and costly in diabetes. In: Current Diabetes Reports. 2015 ; Vol. 15, No. 6. pp. 606.
@article{95e215260c9946f99ee3c37bfb78fc87,
title = "Treating the most vulnerable and costly in diabetes",
abstract = "Diabetic ketoacidosis (DKA) is associated with negative health outcomes and high costs for patients, families, and communities. Interventions developed to effectively reduce DKA and related costs should target the multiple risk factors associated with DKA and adherence difficulties. Certain demographic, psychological, and family factors are associated with increased risk for adherence problems and DKA. Individuals with a combination of risk factors (e.g., mental health problems, low socioeconomic status, high family conflict) may be particularly vulnerable to DKA. Although several different interventions have demonstrated promise in improving adherence and/or decreasing the risk of DKA, the generalizability of treatment results to those individuals most vulnerable to DKA is limited. Approaches which include multiple evidence-based components of care, are flexible in treatment delivery (e.g., home- and community-based, utilize technology), and target the multiple risk factors across relevant systems (e.g., individual, family, school, medical) are warranted to effectively reduce DKA in vulnerable populations.",
author = "Wagner, {David V.} and Maggie Stoeckel and {E. Tudor}, Megan and Michael Harris",
year = "2015",
month = "6",
day = "1",
doi = "10.1007/s11892-015-0606-5",
language = "English (US)",
volume = "15",
pages = "606",
journal = "Current Diabetes Reports",
issn = "1534-4827",
publisher = "Current Medicine Group",
number = "6",

}

TY - JOUR

T1 - Treating the most vulnerable and costly in diabetes

AU - Wagner, David V.

AU - Stoeckel, Maggie

AU - E. Tudor, Megan

AU - Harris, Michael

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Diabetic ketoacidosis (DKA) is associated with negative health outcomes and high costs for patients, families, and communities. Interventions developed to effectively reduce DKA and related costs should target the multiple risk factors associated with DKA and adherence difficulties. Certain demographic, psychological, and family factors are associated with increased risk for adherence problems and DKA. Individuals with a combination of risk factors (e.g., mental health problems, low socioeconomic status, high family conflict) may be particularly vulnerable to DKA. Although several different interventions have demonstrated promise in improving adherence and/or decreasing the risk of DKA, the generalizability of treatment results to those individuals most vulnerable to DKA is limited. Approaches which include multiple evidence-based components of care, are flexible in treatment delivery (e.g., home- and community-based, utilize technology), and target the multiple risk factors across relevant systems (e.g., individual, family, school, medical) are warranted to effectively reduce DKA in vulnerable populations.

AB - Diabetic ketoacidosis (DKA) is associated with negative health outcomes and high costs for patients, families, and communities. Interventions developed to effectively reduce DKA and related costs should target the multiple risk factors associated with DKA and adherence difficulties. Certain demographic, psychological, and family factors are associated with increased risk for adherence problems and DKA. Individuals with a combination of risk factors (e.g., mental health problems, low socioeconomic status, high family conflict) may be particularly vulnerable to DKA. Although several different interventions have demonstrated promise in improving adherence and/or decreasing the risk of DKA, the generalizability of treatment results to those individuals most vulnerable to DKA is limited. Approaches which include multiple evidence-based components of care, are flexible in treatment delivery (e.g., home- and community-based, utilize technology), and target the multiple risk factors across relevant systems (e.g., individual, family, school, medical) are warranted to effectively reduce DKA in vulnerable populations.

UR - http://www.scopus.com/inward/record.url?scp=84953343796&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953343796&partnerID=8YFLogxK

U2 - 10.1007/s11892-015-0606-5

DO - 10.1007/s11892-015-0606-5

M3 - Article

VL - 15

SP - 606

JO - Current Diabetes Reports

JF - Current Diabetes Reports

SN - 1534-4827

IS - 6

ER -